Press release
Insights into Heart Failure Pipeline Report: Clinical Trials, Emerging Therapies, Recent FDA, EMA, PDMA Approvals, and Key Companies by DelveInsight | Featuring Bayer, Juventas Therapeutics, Amgen, GlaxoSmithKline, and others.
Heart Failure Pipeline
Heart failure Overview:
Heart failure, also known as congestive heart failure refers to the condition when heart is not able to pump adequate blood to the body. In the absence of sufficient blood flow, all the major body functions are disrupted. Certain conditions, such as narrowed arteries in the heart (coronary artery disease) or high blood pressure, gradually leave the heart too weak or stiff to fill and pump efficiently. Heart failure can be diagnosed based on the medical and family history, a physical exam, and test results. Treating heart failure depends on the severity of the condition. Diagnostic tests include: electrocardiogram, chest X-Ray, echocardiography etc. Treatments usually include heart-healthy lifestyle changes, medicines, and ongoing care.
Know more about Heart failure Report, click here: https://www.delveinsight.com/report-store/heart-failure-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Some of the Heart failure companies working in the market are:
• Eli Lilly and Company
• Bayer
• BioCardia
• Mesoblast Inc.
• Janssen Research & Development
• Pfizer
• Bristol-Myers Squibb
• Actelion Pharmaceuticals
• Tasly Pharmaceuticals
• Ionis Pharmaceuticals
• Innolife
• Imara Inc
• Bristol-Myers Squibb
• Stealth BioTherapeutics
• Bristol Myers Squibb
• Berlin Cures
• Bayer
• AstraZeneca
• Regeneron Pharmaceuticals
• GlaxoSmithKline
• SQ Innovation
• Recardio
• BIAL
• AstraZeneca
• Bristol Myers Squibb
• Imbria Pharmaceuticals
• Tenaya Therapeutics
• RibomicAnd Many Others
DelveInsight's Heart failure report covers around 90+ products under different phases of clinical development like:
• Late-stage Heart failure products (Phase III)
• Mid-stage Heart failure products (Phase II and Phase I/II)
• Early-stage Heart failure products (Phase I/II and Phase I) along with the details of
• Heart failure Pre-clinical and Discovery stage candidates
• Discontinued & Inactive candidates
Request for Heart failure Pipeline sample report to know in detail about the Heart failure product segmentation: https://www.delveinsight.com/sample-request/heart-failure-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Some of Heart failure Therapies:
• Finerenone (BAY94-8862)
• Omecamtiv Mecarbil
• ACRX-100
• GSK2798745
• LMI 1195-101
• Elamipretide
• FA relaxin
• BMS-986231
• Rexlemestrocel-L
• CardiAMP Cell Therapy
• And Many Others
Click here to know more about the Heart failure therapeutic assessment: https://www.delveinsight.com/report-store/heart-failure-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Current Heart failure Treatment Scenario and Heart failure Emerging Therapies:
• How many companies are developing Heart failure drugs?
• How many Heart failure drugs are developed by each company?
• How many emerging drugs are in mid-stage, and late-stage of development for the treatment of Heart failure?
• What are the key collaborations (Industry-Industry, Industry-Academia), Mergers and acquisitions, licensing activities related to the Heart failure therapeutics?
• What are the recent trends, drug types and novel technologies developed to overcome the limitation of existing therapies?
• What are the clinical studies going on for Heart failure and their status?
• What are the key designations that have been granted to the emerging drugs?
Click here to know more about the recent developments in the heart failure domain: https://www.delveinsight.com/sample-request/heart-failure-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Table of Contents:
• Introduction
• Executive Summary
• Heart Failure: Overview
• Heart Failure Causes
• Heart Failure Mechanism of Action
• Heart Failure Signs and Symptoms
• Heart Failure Diagnosis
• Heart Failure Treatment
• Heart Failure Pipeline Therapeutics
• Comparative Analysis
• Heart Failure Therapeutic Assessment
• Assessment by Product Type
• Assessment by Stage and Product Type
• Assessment by Route of Administration
• Assessment by Stage and Route of Administration
• Assessment by Molecule Type
• Assessment by Stage and Molecule Type
• Heart Failure - DelveInsight's Analytical Perspective
• Late Stage Products (Phase III)
• Comparative Analysis
• Tirzepatide: Eli Lilly and Company
• Product Description
• Research and Development
• Product Development Activities
• Drug profiles in the detailed report…..
• Mid Stage Products (Phase II)
• Comparative Analysis
• AZD-8601: AstraZeneca
• Product Description
• Research and Development
• Product Development Activities
• Drug profiles in the detailed report…..
• Early Stage Products (Phase I/II)
• Comparative Analysis
• Drug name: Company name
• Product Description
• Research and Development
• Product Development Activities
• Drug profiles in the detailed report…..
• Early Stage Products (Phase I)
• Comparative Analysis
• AZD-3427: AstraZeneca
• Product Description
• Research and Development
• Product Development Activities
• Drug profiles in the detailed report…..
• Preclinical and Discovery Stage Products
• Comparative Analysis
• RBM-003: Ribomic
• Product Description
• Research and Development
• Product Development Activities
• Drug profiles in the detailed report…..
• Inactive Products
• Comparative Analysis
• Heart Failure Key Companies
• Heart Failure Key Products
• Heart Failure Unmet Needs
• Heart Failure Market Drivers and Barriers
• Heart Failure - Future Perspectives and Conclusion
• Heart Failure Analyst Views
• Heart Failure Key Companies
• Appendix
Request for Detailed TOC: https://www.delveinsight.com/sample-request/heart-failure-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Trending Reports:
• Central Serous Chorioretinopathy Market: https://www.delveinsight.com/report-store/central-serous-chorioretinopathy-market
• Conference Coverage Services: https://www.delveinsight.com/consulting/conference-coverage-services
• Generalized Pustular Psoriasis Market: https://www.delveinsight.com/report-store/generalized-pustular-psoriasis-gpp-market
• Hemorrhagic Cystitis Market: https://www.delveinsight.com/report-store/hemorrhagic-cystitis-market
• Menorrhalgia Market: https://www.delveinsight.com/report-store/menorrhalgia-market
• Ocular Motility Disturbance Market: https://www.delveinsight.com/report-store/ocular-motility-disturbance-market
• Post-bariatric Hypoglycemia Market: https://www.delveinsight.com/report-store/post-bariatric-hypoglycemia-market
• Thrombotic Microangiopathy Market: https://www.delveinsight.com/report-store/thrombotic-microangiopathy-tma-market
• Vascular Dementia Market: https://www.delveinsight.com/report-store/vascular-dementia-market
• Acute Heart Failure Ahf Market: https://www.delveinsight.com/report-store/acute-heart-failure-ahf-market
• Acute Ischemic Stroke Ais Market: https://www.delveinsight.com/report-store/acute-ischemic-stroke-ais-market
• Bartonellosis Market: https://www.delveinsight.com/report-store/bartonellosis-market
• Biliary Tract Carcinoma Market: https://www.delveinsight.com/report-store/biliary-tract-cancers-btcs-market
• Chronic Idiopathic Urticaria Market: https://www.delveinsight.com/report-store/chronic-spontaneous-urticaria-market
• Epithelioid Sarcoma Market: https://www.delveinsight.com/report-store/epithelioid-sarcoma-market
• Glycogen Storage Disease Market: https://www.delveinsight.com/report-store/glycogen-storage-disease-market
• Hyperinsulinemic Hypoglycemia Market: https://www.delveinsight.com/report-store/congenital-hyperinsulinism-market
• Neurofibromatosis 2 Market: https://www.delveinsight.com/report-store/neurofibromatosis-type-2-market-insight
• Phosphoglucomutase Pgm 1 Deficiency Market: https://www.delveinsight.com/report-store/phosphoglucomutase-pgm-1-deficiency-market?utm_source=delveinsight&utm_medium=report%20promotion&utm_campaign=yash
• Polycythemia Vera Market: https://www.delveinsight.com/report-store/polycythemia-vera-market
• Refractory Chronic Cough Market: https://www.delveinsight.com/report-store/chronic-refractory-cough-market
• Vestibular Schwannoma Market: https://www.delveinsight.com/report-store/vestibular-schwannoma-market
• Advanced Hepatocellular Carcinoma With Cpb Liver Cirrhosis Market: https://www.delveinsight.com/report-store/advanced-hepatocellular-carcinoma-with-cpb-liver-cirrhosis-pipeline-insight
• Ankylosing Spondylitis Bekhterevs Disease Market: https://www.delveinsight.com/report-store/ankylosing-spondylitis-bekhterevs-disease-market
• Balloon Catheters Market Market: https://www.delveinsight.com/report-store/balloon-catheters-market
• Cellulitis Market: https://www.delveinsight.com/report-store/cellulitis-market
• Cerebral Vein Thrombosis Market: https://www.delveinsight.com/report-store/cerebral-vein-thrombosis-market
• Fibrocystic Breast Condition Market: https://www.delveinsight.com/report-store/fibrocystic-breast-condition-market
• Idiopathic Membranous Nephropathy Market: https://www.delveinsight.com/report-store/idiopathic-membranous-nephropathy-market
• Mydriasis Market: https://www.delveinsight.com/report-store/mydriasis-market
• Artificial Iris Market: https://www.delveinsight.com/report-store/artificial-iris-market
• Bronchopulmonary Dysplasia Market: https://www.delveinsight.com/blog/bronchopulmonary-dysplasia-treatment-market
• Chronic Gout Market: https://www.delveinsight.com/report-store/chronic-gout-market
• Dermal Erythema Market: https://www.delveinsight.com/report-store/dermal-erythema-market
• Dysthymia Market: https://www.delveinsight.com/report-store/dysthymia-market
• Spinal Stenosis Market: https://www.delveinsight.com/report-store/spinal-stenosis-devices-market
• Wegener S Granulomatosis/granulomatosis With Polyangiitis Market: https://www.delveinsight.com/report-store/wegeners-granulomatosis-market
Contact us
Ankit Nigam
info@delveinsight.com
+91-9650213330
https://www.delveinsight.com
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end-to-end comprehensive solutions to improve their performance. Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Insights into Heart Failure Pipeline Report: Clinical Trials, Emerging Therapies, Recent FDA, EMA, PDMA Approvals, and Key Companies by DelveInsight | Featuring Bayer, Juventas Therapeutics, Amgen, GlaxoSmithKline, and others. here
News-ID: 3346155 • Views: …
More Releases from DelveInsight Business Research
Pharma Asset Management Success Story: Strategic In-Licensing in the Atrial Fibr …
DelveInsight, a leading business consulting and market research firm, is pleased to announce the successful completion of an Asset Prioritization project that enabled a mid-sized pharmaceutical client to identify, evaluate, and secure a high-value therapeutic asset for in-licensing in the Atrial Fibrillation (AF) space. The case study highlights how evidence-based insights, structured methodologies, and multi-layered evaluations supported the client in achieving its long-term strategic growth goals.
Objective of the Case Study
The…
Myopia Clinical Trials Outlook 2025: Competitive Landscape, Regulatory Milestone …
(Albany, USA) - DelveInsight's newly released report, "Myopia Pipeline Insight 2025," delivers an in-depth assessment of the clinical trial landscape, regulatory progress, and therapeutic development trends shaping the Myopia therapeutics market. The analysis highlights ongoing clinical advancements, pipeline opportunities, and the potential impact of emerging therapies on patient care and market dynamics.
According to DelveInsight's evaluation, the Myopia pipeline remains highly active, with 8+ pharmaceutical and biotechnology companies investigating more than…
Global Biopsy Devices Market to Reach USD 10.81 Billion by 2032, Driven by Risin …
The global biopsy devices market is poised for significant growth, with market size projected to increase from USD 5,813.16 million in 2024 to USD 10,812.77 million by 2032, expanding at a CAGR of 8.09% during 2025-2032. The robust expansion is being driven by the growing incidence of cancers, rising demand for minimally invasive diagnostic procedures, and rapid advancements in biopsy technologies.
Biopsy devices play a crucial role in disease diagnosis by…
Global General Surgery Devices Market to Reach USD 35.4 Billion by 2032, Driven …
According to the latest market analysis, the global general surgery devices market is set for robust growth, increasing from USD 21,786.29 million in 2024 to USD 35,399.63 million by 2032, expanding at a CAGR of 6.34% during 2025-2032. This growth reflects a surge in surgical procedures, continuous technological advancements, and rising demand for minimally invasive and robotic-assisted surgical techniques across healthcare systems worldwide.
DelveInsight's General Surgery Devices Market Report 2032 provides…
More Releases for Heart
Heart Healthy Foods and Supplements vs Heart Conditions
Heart conditions remain a major health concern worldwide, but the good news is that specific heart healthy foods and supplements can significantly improve cardiovascular health.
Scientific research has demonstrated that certain foods, nutrients and supplements support heart function, reduce inflammation, and lower the risk of heart disease.
Top Heart Healthy Foods
Fatty Fish - Salmon, mackerel, and sardines are rich in omega-3 fatty acids, which help lower blood pressure and reduce inflammation. A…
Centrifugal Heart Pumps Market | Abbott Laboratories, Abiomed, Berlin Heart, Car …
The global centrifugal heart pumps market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the centrifugal heart pumps market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants.
From the perspective of market dynamics, this report explores the factors driving the growth…
Heart disease and Heart Attacks - Kaffailham.gr
Καρδιολόγος Αθηνα - https://kaffailham.gr
When people talk about heart disease or heart attacks. The arteries that they are talking about are the arteries that actually provide blood to the heart. Remember the heart itself is a muscle. It itself needs oxygen. So you have these arteries right over here, the red tubes. Those are arteries. and then the blue ones are veins. They're taking the de-oxygenated blood away from the tissue…
Artificial Heart Implant Market May See a Big Move | Major Giants Jarvik Heart, …
The Latest survey report on Artificial Heart Implant Market sheds lights on changing dynamics of each of the subsegments of Industry. As the shift to value continues, Artificial Heart Implant organizations have the dual challenge of increasing interoperability to improve clinical performance and the patient experience. Some of the companies listed in the study from complete survey list are Medtronic, Boston Scientific, Abbott, Terumo, B.Braun, SynCardia, BiVACOR, CARMAT, ReinHeart TAH…
HEART PUMP DEVICES Market 2020 | SWOT Analysis By Top Players Abbott Laboratorie …
A detailed study on HEART PUMP DEVICES Market formulated by Brandessence Market Research, puts together a concise analysis of the growth factors impacting the current business scenario across assorted regions. Significant information pertaining to the industry's size, share, application, and statistics are also summed in the report in order to present an ensemble prediction. In addition, this report undertakes an accurate competitive analysis illustrating the status of market majors in…
Heart Pump Device Market - Potential Innovations 2025 | Terumo, Jarvik Heart
Heart Pump Device Market: Snapshot
Heart pump devices are essentially mechanical pumps playing the role of ventricular assist devices. These are surgically implanted and are used for temporarily supporting the functions of heart in people with weak heart or irregular blood flow. These devices are notably used as a bridge to cardiac transplantation for patients suffering with end stage heart failure. They can also be used in patients during and after…
